The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dasatinib API Market Research Report 2024
Synopsis
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Dasatinib is commonly associated with transient elevations in serum aminotransferase levels during treatment, but with only rare instances of clinically apparent acute liver injury.
The global Dasatinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dasatinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dasatinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dasatinib API include Dr. Reddy's Laboratories, ChemWerth Inc, Teva API, Sun Pharmaceutical, Hubei Haosun Pharmaceutical, ALP Pharm, Sichuan Xieli Pharmaceutical and Boryung Pharmaceutical Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dasatinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dasatinib API.
Report Scope
The Dasatinib API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dasatinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dasatinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy's Laboratories
ChemWerth Inc
Teva API
Sun Pharmaceutical
Hubei Haosun Pharmaceutical
ALP Pharm
Sichuan Xieli Pharmaceutical
Boryung Pharmaceutical Co., Ltd
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Dasatinib Tablets
Others
Production by Region
North America
India
China
South Korea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dasatinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dasatinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dasatinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Dasatinib is commonly associated with transient elevations in serum aminotransferase levels during treatment, but with only rare instances of clinically apparent acute liver injury.
The global Dasatinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dasatinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dasatinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dasatinib API include Dr. Reddy's Laboratories, ChemWerth Inc, Teva API, Sun Pharmaceutical, Hubei Haosun Pharmaceutical, ALP Pharm, Sichuan Xieli Pharmaceutical and Boryung Pharmaceutical Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dasatinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dasatinib API.
Report Scope
The Dasatinib API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dasatinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dasatinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy's Laboratories
ChemWerth Inc
Teva API
Sun Pharmaceutical
Hubei Haosun Pharmaceutical
ALP Pharm
Sichuan Xieli Pharmaceutical
Boryung Pharmaceutical Co., Ltd
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Dasatinib Tablets
Others
Production by Region
North America
India
China
South Korea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dasatinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dasatinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dasatinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Dasatinib API Market Overview
1.1 Product Definition
1.2 Dasatinib API Segment by Type
1.2.1 Global Dasatinib API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Dasatinib API Segment by Application
1.3.1 Global Dasatinib API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Dasatinib Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Dasatinib API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dasatinib API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dasatinib API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dasatinib API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dasatinib API Production Market Share by Manufacturers (2019-2024)
2.2 Global Dasatinib API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dasatinib API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Dasatinib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Dasatinib API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dasatinib API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dasatinib API, Product Offered and Application
2.8 Global Key Manufacturers of Dasatinib API, Date of Enter into This Industry
2.9 Dasatinib API Market Competitive Situation and Trends
2.9.1 Dasatinib API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dasatinib API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dasatinib API Production by Region
3.1 Global Dasatinib API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dasatinib API Production Value by Region (2019-2030)
3.2.1 Global Dasatinib API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dasatinib API by Region (2025-2030)
3.3 Global Dasatinib API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dasatinib API Production by Region (2019-2030)
3.4.1 Global Dasatinib API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dasatinib API by Region (2025-2030)
3.5 Global Dasatinib API Market Price Analysis by Region (2019-2024)
3.6 Global Dasatinib API Production and Value, Year-over-Year Growth
3.6.1 North America Dasatinib API Production Value Estimates and Forecasts (2019-2030)
3.6.2 India Dasatinib API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Dasatinib API Production Value Estimates and Forecasts (2019-2030)
3.6.4 South Korea Dasatinib API Production Value Estimates and Forecasts (2019-2030)
4 Dasatinib API Consumption by Region
4.1 Global Dasatinib API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dasatinib API Consumption by Region (2019-2030)
4.2.1 Global Dasatinib API Consumption by Region (2019-2024)
4.2.2 Global Dasatinib API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dasatinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dasatinib API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dasatinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dasatinib API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dasatinib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dasatinib API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dasatinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dasatinib API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Dasatinib API Production by Type (2019-2030)
5.1.1 Global Dasatinib API Production by Type (2019-2024)
5.1.2 Global Dasatinib API Production by Type (2025-2030)
5.1.3 Global Dasatinib API Production Market Share by Type (2019-2030)
5.2 Global Dasatinib API Production Value by Type (2019-2030)
5.2.1 Global Dasatinib API Production Value by Type (2019-2024)
5.2.2 Global Dasatinib API Production Value by Type (2025-2030)
5.2.3 Global Dasatinib API Production Value Market Share by Type (2019-2030)
5.3 Global Dasatinib API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dasatinib API Production by Application (2019-2030)
6.1.1 Global Dasatinib API Production by Application (2019-2024)
6.1.2 Global Dasatinib API Production by Application (2025-2030)
6.1.3 Global Dasatinib API Production Market Share by Application (2019-2030)
6.2 Global Dasatinib API Production Value by Application (2019-2030)
6.2.1 Global Dasatinib API Production Value by Application (2019-2024)
6.2.2 Global Dasatinib API Production Value by Application (2025-2030)
6.2.3 Global Dasatinib API Production Value Market Share by Application (2019-2030)
6.3 Global Dasatinib API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Dasatinib API Corporation Information
7.1.2 Dr. Reddy's Laboratories Dasatinib API Product Portfolio
7.1.3 Dr. Reddy's Laboratories Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.2 ChemWerth Inc
7.2.1 ChemWerth Inc Dasatinib API Corporation Information
7.2.2 ChemWerth Inc Dasatinib API Product Portfolio
7.2.3 ChemWerth Inc Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 ChemWerth Inc Main Business and Markets Served
7.2.5 ChemWerth Inc Recent Developments/Updates
7.3 Teva API
7.3.1 Teva API Dasatinib API Corporation Information
7.3.2 Teva API Dasatinib API Product Portfolio
7.3.3 Teva API Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Teva API Main Business and Markets Served
7.3.5 Teva API Recent Developments/Updates
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Dasatinib API Corporation Information
7.4.2 Sun Pharmaceutical Dasatinib API Product Portfolio
7.4.3 Sun Pharmaceutical Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Sun Pharmaceutical Main Business and Markets Served
7.4.5 Sun Pharmaceutical Recent Developments/Updates
7.5 Hubei Haosun Pharmaceutical
7.5.1 Hubei Haosun Pharmaceutical Dasatinib API Corporation Information
7.5.2 Hubei Haosun Pharmaceutical Dasatinib API Product Portfolio
7.5.3 Hubei Haosun Pharmaceutical Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Hubei Haosun Pharmaceutical Main Business and Markets Served
7.5.5 Hubei Haosun Pharmaceutical Recent Developments/Updates
7.6 ALP Pharm
7.6.1 ALP Pharm Dasatinib API Corporation Information
7.6.2 ALP Pharm Dasatinib API Product Portfolio
7.6.3 ALP Pharm Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 ALP Pharm Main Business and Markets Served
7.6.5 ALP Pharm Recent Developments/Updates
7.7 Sichuan Xieli Pharmaceutical
7.7.1 Sichuan Xieli Pharmaceutical Dasatinib API Corporation Information
7.7.2 Sichuan Xieli Pharmaceutical Dasatinib API Product Portfolio
7.7.3 Sichuan Xieli Pharmaceutical Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Sichuan Xieli Pharmaceutical Main Business and Markets Served
7.7.5 Sichuan Xieli Pharmaceutical Recent Developments/Updates
7.8 Boryung Pharmaceutical Co., Ltd
7.8.1 Boryung Pharmaceutical Co., Ltd Dasatinib API Corporation Information
7.8.2 Boryung Pharmaceutical Co., Ltd Dasatinib API Product Portfolio
7.8.3 Boryung Pharmaceutical Co., Ltd Dasatinib API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
7.7.5 Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dasatinib API Industry Chain Analysis
8.2 Dasatinib API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dasatinib API Production Mode & Process
8.4 Dasatinib API Sales and Marketing
8.4.1 Dasatinib API Sales Channels
8.4.2 Dasatinib API Distributors
8.5 Dasatinib API Customers
9 Dasatinib API Market Dynamics
9.1 Dasatinib API Industry Trends
9.2 Dasatinib API Market Drivers
9.3 Dasatinib API Market Challenges
9.4 Dasatinib API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dasatinib API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Dasatinib API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Dasatinib API Production Capacity (Kiloton) by Manufacturers in 2023
Table 4. Global Dasatinib API Production by Manufacturers (2019-2024) & (Kiloton)
Table 5. Global Dasatinib API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Dasatinib API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Dasatinib API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Dasatinib API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dasatinib API as of 2023)
Table 10. Global Market Dasatinib API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Dasatinib API Production Sites and Area Served
Table 12. Manufacturers Dasatinib API Product Types
Table 13. Global Dasatinib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Dasatinib API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Dasatinib API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Dasatinib API Production Value Market Share by Region (2019-2024)
Table 18. Global Dasatinib API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Dasatinib API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Dasatinib API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 21. Global Dasatinib API Production (Kiloton) by Region (2019-2024)
Table 22. Global Dasatinib API Production Market Share by Region (2019-2024)
Table 23. Global Dasatinib API Production (Kiloton) Forecast by Region (2025-2030)
Table 24. Global Dasatinib API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Dasatinib API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Dasatinib API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Dasatinib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 28. Global Dasatinib API Consumption by Region (2019-2024) & (Kiloton)
Table 29. Global Dasatinib API Consumption Market Share by Region (2019-2024)
Table 30. Global Dasatinib API Forecasted Consumption by Region (2025-2030) & (Kiloton)
Table 31. Global Dasatinib API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Dasatinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 33. North America Dasatinib API Consumption by Country (2019-2024) & (Kiloton)
Table 34. North America Dasatinib API Consumption by Country (2025-2030) & (Kiloton)
Table 35. Europe Dasatinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 36. Europe Dasatinib API Consumption by Country (2019-2024) & (Kiloton)
Table 37. Europe Dasatinib API Consumption by Country (2025-2030) & (Kiloton)
Table 38. Asia Pacific Dasatinib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 39. Asia Pacific Dasatinib API Consumption by Region (2019-2024) & (Kiloton)
Table 40. Asia Pacific Dasatinib API Consumption by Region (2025-2030) & (Kiloton)
Table 41. Latin America, Middle East & Africa Dasatinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 42. Latin America, Middle East & Africa Dasatinib API Consumption by Country (2019-2024) & (Kiloton)
Table 43. Latin America, Middle East & Africa Dasatinib API Consumption by Country (2025-2030) & (Kiloton)
Table 44. Global Dasatinib API Production (Kiloton) by Type (2019-2024)
Table 45. Global Dasatinib API Production (Kiloton) by Type (2025-2030)
Table 46. Global Dasatinib API Production Market Share by Type (2019-2024)
Table 47. Global Dasatinib API Production Market Share by Type (2025-2030)
Table 48. Global Dasatinib API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Dasatinib API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Dasatinib API Production Value Share by Type (2019-2024)
Table 51. Global Dasatinib API Production Value Share by Type (2025-2030)
Table 52. Global Dasatinib API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Dasatinib API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Dasatinib API Production (Kiloton) by Application (2019-2024)
Table 55. Global Dasatinib API Production (Kiloton) by Application (2025-2030)
Table 56. Global Dasatinib API Production Market Share by Application (2019-2024)
Table 57. Global Dasatinib API Production Market Share by Application (2025-2030)
Table 58. Global Dasatinib API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Dasatinib API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Dasatinib API Production Value Share by Application (2019-2024)
Table 61. Global Dasatinib API Production Value Share by Application (2025-2030)
Table 62. Global Dasatinib API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Dasatinib API Price (US$/Ton) by Application (2025-2030)
Table 64. Dr. Reddy's Laboratories Dasatinib API Corporation Information
Table 65. Dr. Reddy's Laboratories Specification and Application
Table 66. Dr. Reddy's Laboratories Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Dr. Reddy's Laboratories Main Business and Markets Served
Table 68. Dr. Reddy's Laboratories Recent Developments/Updates
Table 69. ChemWerth Inc Dasatinib API Corporation Information
Table 70. ChemWerth Inc Specification and Application
Table 71. ChemWerth Inc Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. ChemWerth Inc Main Business and Markets Served
Table 73. ChemWerth Inc Recent Developments/Updates
Table 74. Teva API Dasatinib API Corporation Information
Table 75. Teva API Specification and Application
Table 76. Teva API Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Teva API Main Business and Markets Served
Table 78. Teva API Recent Developments/Updates
Table 79. Sun Pharmaceutical Dasatinib API Corporation Information
Table 80. Sun Pharmaceutical Specification and Application
Table 81. Sun Pharmaceutical Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Sun Pharmaceutical Main Business and Markets Served
Table 83. Sun Pharmaceutical Recent Developments/Updates
Table 84. Hubei Haosun Pharmaceutical Dasatinib API Corporation Information
Table 85. Hubei Haosun Pharmaceutical Specification and Application
Table 86. Hubei Haosun Pharmaceutical Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Hubei Haosun Pharmaceutical Main Business and Markets Served
Table 88. Hubei Haosun Pharmaceutical Recent Developments/Updates
Table 89. ALP Pharm Dasatinib API Corporation Information
Table 90. ALP Pharm Specification and Application
Table 91. ALP Pharm Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. ALP Pharm Main Business and Markets Served
Table 93. ALP Pharm Recent Developments/Updates
Table 94. Sichuan Xieli Pharmaceutical Dasatinib API Corporation Information
Table 95. Sichuan Xieli Pharmaceutical Specification and Application
Table 96. Sichuan Xieli Pharmaceutical Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Sichuan Xieli Pharmaceutical Main Business and Markets Served
Table 98. Sichuan Xieli Pharmaceutical Recent Developments/Updates
Table 99. Boryung Pharmaceutical Co., Ltd Dasatinib API Corporation Information
Table 100. Boryung Pharmaceutical Co., Ltd Specification and Application
Table 101. Boryung Pharmaceutical Co., Ltd Dasatinib API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Boryung Pharmaceutical Co., Ltd Main Business and Markets Served
Table 103. Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
Table 104. Key Raw Materials Lists
Table 105. Raw Materials Key Suppliers Lists
Table 106. Dasatinib API Distributors List
Table 107. Dasatinib API Customers List
Table 108. Dasatinib API Market Trends
Table 109. Dasatinib API Market Drivers
Table 110. Dasatinib API Market Challenges
Table 111. Dasatinib API Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dasatinib API
Figure 2. Global Dasatinib API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Dasatinib API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Dasatinib API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Dasatinib API Market Share by Application: 2023 VS 2030
Figure 8. Dasatinib Tablets
Figure 9. Others
Figure 10. Global Dasatinib API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Dasatinib API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Dasatinib API Production Capacity (Kiloton) & (2019-2030)
Figure 13. Global Dasatinib API Production (Kiloton) & (2019-2030)
Figure 14. Global Dasatinib API Average Price (US$/Ton) & (2019-2030)
Figure 15. Dasatinib API Report Years Considered
Figure 16. Dasatinib API Production Share by Manufacturers in 2023
Figure 17. Dasatinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Dasatinib API Revenue in 2023
Figure 19. Global Dasatinib API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Dasatinib API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Dasatinib API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 22. Global Dasatinib API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Dasatinib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. India Dasatinib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Dasatinib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. South Korea Dasatinib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Dasatinib API Consumption by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 28. Global Dasatinib API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 30. North America Dasatinib API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 32. U.S. Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 33. Europe Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 34. Europe Dasatinib API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 36. France Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 37. U.K. Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 38. Italy Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 39. Russia Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 40. Asia Pacific Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 41. Asia Pacific Dasatinib API Consumption Market Share by Regions (2019-2030)
Figure 42. China Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 43. Japan Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 44. South Korea Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 45. China Taiwan Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 46. Southeast Asia Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 47. India Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 48. Latin America, Middle East & Africa Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 49. Latin America, Middle East & Africa Dasatinib API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 51. Brazil Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 52. Turkey Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 53. GCC Countries Dasatinib API Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 54. Global Production Market Share of Dasatinib API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Dasatinib API by Type (2019-2030)
Figure 56. Global Dasatinib API Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Dasatinib API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Dasatinib API by Application (2019-2030)
Figure 59. Global Dasatinib API Price (US$/Ton) by Application (2019-2030)
Figure 60. Dasatinib API Value Chain
Figure 61. Dasatinib API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
